Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02311543 | Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer | completed | Phase 3 | 142 | Swiss Cancer InstituteOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT00776724 | Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm(TaiNAC) | completed | Phase 3 | 166 | National Taiwan University HospitalOTHER | 1 | May 6, 2019 |
| NCT01953003 | Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer | completed | Phase 3 | 112 | Pierre Fabre MedicamentINDUSTRY | 3 | May 2, 2019 | clinicaltrials |
| NCT02253459 | Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer | completed | Phase 3 | 405 | Beijing Biostar Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Apr 9, 2019 | clinicaltrials |
| NCT03888677 | Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer | completed | Phase 3 | 1,535 | Henrik LindmanOTHER | 0 | Mar 28, 2019 | clinicaltrials |
| NCT00418028 | Standard Versus Continuous Capecitabine in Advanced Breast Cancer | completed | Phase 2 / Phase 3 | 195 | Hospital San Carlos, MadridOTHER | 1 | Feb 22, 2019 | clinicaltrials |
| NCT01881230 | Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)(tnAcity) | completed | Phase 2 / Phase 3 | 191 | CelgeneINDUSTRY | 12 | Feb 21, 2019 | clinicaltrials |
| NCT01376349 | Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms | completed | Phase 3 | 464 | Alliance for Clinical Trials in OncologyOTHER | 1 | Feb 7, 2019 | clinicaltrials |
| NCT03240224 | Bioinformation Therapy for Breast Cancer | completed | Phase 2 / Phase 3 | 120 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT00513292 | Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery | completed | Phase 3 | 280 | National Cancer Institute (NCI)NIH | 2 | Jan 23, 2019 | clinicaltrials |
| NCT00876395 | Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer(BOLERO-1) | completed | Phase 3 | 719 | Novartis PharmaceuticalsINDUSTRY | 28 | Dec 19, 2018 | clinicaltrials |
| NCT01073865 | Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer | completed | Phase 3 | 222 | AstraZenecaINDUSTRY | 6 | Dec 12, 2018 | clinicaltrials |
| NCT00046865 | Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer | completed | Phase 3 | 57 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT00869206 | Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement | completed | Phase 3 | 1,822 | Alliance for Clinical Trials in OncologyOTHER | 2 | Nov 7, 2018 | clinicaltrials |
| NCT00002836 | Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer | completed | Phase 3 | 184 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT00089661 | AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer | completed | Phase 3 | 252 | AmgenINDUSTRY | 0 | Oct 17, 2018 | clinicaltrials |
| NCT00793962 | A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer | completed | Phase 3 | 810 | Chinese Academy of Medical SciencesOTHER | 1 | Oct 11, 2018 | clinicaltrials |
| NCT00639106 | Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial | completed | Phase 3 | 70 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 3, 2018 | clinicaltrials |
| NCT00053898 | Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy | completed | Phase 3 | 3,104 | NSABP Foundation IncNETWORK | 3 | Sep 20, 2018 | clinicaltrials |
| NCT01638247 | Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients(MALE) | completed | Phase 3 | 56 | GBG Forschungs GmbHOTHER | 1 | Sep 19, 2018 | clinicaltrials |
| NCT02019277 | A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer(SAPPHIRE) | completed | Phase 3 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Sep 13, 2018 | clinicaltrials |
| NCT02225470 | Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes | completed | Phase 3 | 530 | Eisai Co., Ltd.INDUSTRY | 1 | Aug 28, 2018 | clinicaltrials |
| NCT01026142 | A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA) | completed | Phase 3 | 452 | Hoffmann-La RocheINDUSTRY | 23 | Aug 14, 2018 | clinicaltrials |
| NCT01942980 | Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-Brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast Cancer | completed | Phase 3 | 8 | Institut Paoli-CalmettesOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT00002942 | Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer | completed | Phase 3 | 136 | Wake Forest University Health SciencesOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT00195013 | Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy | completed | Phase 3 | 30 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01668914 | Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive(IMSLNB-CANP) | completed | Phase 3 | 126 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT00338286 | A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy | completed | Phase 3 | 2,098 | Janssen Research & Development, LLCINDUSTRY | 21 | Mar 19, 2018 | clinicaltrials |
| NCT01792999 | Koning Breast CT for Breast Imaging in China | completed | Phase 3 | 418 | Koning (Tianjin) Medical Equipment Co., LtdINDUSTRY | 1 | Mar 7, 2018 | clinicaltrials |
| NCT01724450 | Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity(Ceccy) | completed | Phase 3 | 200 | University of Sao PauloOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00950300 | A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer | completed | Phase 3 | 596 | Hoffmann-La RocheINDUSTRY | 26 | Jan 23, 2018 | clinicaltrials |
| NCT00093795 | Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer | completed | Phase 3 | 4,894 | NSABP Foundation IncNETWORK | 1 | Jan 11, 2018 | clinicaltrials |
| NCT00003830 | Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer | completed | Phase 3 | 5,611 | NSABP Foundation IncNETWORK | 3 | Dec 13, 2017 | clinicaltrials |
| NCT00009945 | Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 3 | 3,323 | NSABP Foundation IncNETWORK | 1 | Dec 13, 2017 | clinicaltrials |
| NCT00004205 | Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer(BIG 1-98) | completed | Phase 3 | 8,028 | ETOP IBCSG Partners FoundationNETWORK | 3 | Dec 12, 2017 | clinicaltrials |
| NCT00382018 | S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo | completed | Phase 3 | 624 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02483767 | Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer(POF) | completed | Phase 3 | 98 | Peking Union Medical College HospitalOTHER | 0 | Oct 17, 2017 | clinicaltrials |
| NCT00535418 | Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers | completed | Phase 2 / Phase 3 | 35 | Novartis PharmaceuticalsINDUSTRY | 0 | Sep 5, 2017 | clinicaltrials |
| NCT01516736 | Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim(PROTECT2) | completed | Phase 3 | 308 | SandozINDUSTRY | 8 | Aug 30, 2017 | clinicaltrials |
| NCT02001506 | Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer(Neo-shorter) | completed | Phase 3 | 250 | Asan Medical CenterOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT01712893 | Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer | completed | Phase 3 | 216 | Fudan UniversityOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT01495650 | Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving an Adjuvant Treatment(APAD) | completed | Phase 3 | 240 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Aug 21, 2017 | clinicaltrials |
| NCT00775645 | S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo | completed | Phase 3 | 437 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 14, 2017 | clinicaltrials |
| NCT02286778 | Eradication of Malignant Carcinoma in the Breast Tissue | completed | Phase 2 / Phase 3 | 60 | Optimal Health ResearchOTHER | 0 | Aug 3, 2017 | clinicaltrials |
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | completed | Phase 3 | 961 | GBG Forschungs GmbHOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT00789581 | A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer(TITAN) | completed | Phase 3 | 614 | SCRI Development Innovations, LLCOTHER | 2 | Jul 2, 2017 | clinicaltrials |
Data updated 23 days agoSource updated May 15, 2019source: clinicaltrials